FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Deutsche Boerse AG 20:50:23 17/05/2024 BST | ||
| 44.37 EUR | +11.68% |
|
| Current month | +32.21% | ||
| 1 month | +179.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 44.37 | +11.68% |
| 16/05/24 | 39.73 | +16.99% |
| 15/05/24 | 33.96 | +13.73% |
| 14/05/24 | 29.86 | -14.17% |
| 13/05/24 | 34.79 | +12.88% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 08:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PC12QD |
| ISIN | DE000PC12QD4 |
| Date issued | 07/11/2023 |
| Strike | 142.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 148 € |
|---|---|
| Lowest since issue | 11.64 € |
| Spread | 1.41 € |
| Spread % | 3.03% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
144.3
USD
Average target price
146.8
USD
Spread / Average Target
+1.70%
- Stock Market
- Certificates
- Certificat
